| Dr Katelin Marie Morrissette, MD | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-1158 | |
| Not Available |
| Full Name | Dr Katelin Marie Morrissette |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 11 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639515414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 042.0013975 (Vermont) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 042.0013975 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
| Champlain Valley Physicians Hospital Medical Center | 2769396878 | 233 |
News Archive
Newfoundlanders have shown they care by contributing to World Vision's efforts to support the victims the devastating earthquake in Haiti.
The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter.
Faculty members from the Indiana University School of Public Health-Bloomington and the school's Center for Sexual Health Promotion recently published a paper in the Journal of Sex & Marital Therapy focused on addressing gaps in scientific understanding of women's sexual pleasure.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
For the first time, researchers have identified a reliable marker (PDGFRβ) to detect carcinoma-associated fibroblasts (cells within the tumor that encourage growth and metastasis) (CAFs) in oral cancer tissues. With this discovery, anti-PDGFRβ treatment could soon be combined with existing tumor treatments to provide a more effective cancer therapy.
› Verified 8 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Newfoundlanders have shown they care by contributing to World Vision's efforts to support the victims the devastating earthquake in Haiti.
The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter.
Faculty members from the Indiana University School of Public Health-Bloomington and the school's Center for Sexual Health Promotion recently published a paper in the Journal of Sex & Marital Therapy focused on addressing gaps in scientific understanding of women's sexual pleasure.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
For the first time, researchers have identified a reliable marker (PDGFRβ) to detect carcinoma-associated fibroblasts (cells within the tumor that encourage growth and metastasis) (CAFs) in oral cancer tissues. With this discovery, anti-PDGFRβ treatment could soon be combined with existing tumor treatments to provide a more effective cancer therapy.
› Verified 8 days ago
| Entity Name | Rutland Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578527578 PECOS PAC ID: 7214846377 Enrollment ID: O20040427000707 |
News Archive
Newfoundlanders have shown they care by contributing to World Vision's efforts to support the victims the devastating earthquake in Haiti.
The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter.
Faculty members from the Indiana University School of Public Health-Bloomington and the school's Center for Sexual Health Promotion recently published a paper in the Journal of Sex & Marital Therapy focused on addressing gaps in scientific understanding of women's sexual pleasure.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
For the first time, researchers have identified a reliable marker (PDGFRβ) to detect carcinoma-associated fibroblasts (cells within the tumor that encourage growth and metastasis) (CAFs) in oral cancer tissues. With this discovery, anti-PDGFRβ treatment could soon be combined with existing tumor treatments to provide a more effective cancer therapy.
› Verified 8 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Newfoundlanders have shown they care by contributing to World Vision's efforts to support the victims the devastating earthquake in Haiti.
The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter.
Faculty members from the Indiana University School of Public Health-Bloomington and the school's Center for Sexual Health Promotion recently published a paper in the Journal of Sex & Marital Therapy focused on addressing gaps in scientific understanding of women's sexual pleasure.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
For the first time, researchers have identified a reliable marker (PDGFRβ) to detect carcinoma-associated fibroblasts (cells within the tumor that encourage growth and metastasis) (CAFs) in oral cancer tissues. With this discovery, anti-PDGFRβ treatment could soon be combined with existing tumor treatments to provide a more effective cancer therapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katelin Marie Morrissette, MD 1 Medical Center Dr, Dhmc Department Of Emergency Medicine, Lebanon, NH 03756-1000 Ph: () - | Dr Katelin Marie Morrissette, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-1158 |
News Archive
Newfoundlanders have shown they care by contributing to World Vision's efforts to support the victims the devastating earthquake in Haiti.
The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter.
Faculty members from the Indiana University School of Public Health-Bloomington and the school's Center for Sexual Health Promotion recently published a paper in the Journal of Sex & Marital Therapy focused on addressing gaps in scientific understanding of women's sexual pleasure.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
For the first time, researchers have identified a reliable marker (PDGFRβ) to detect carcinoma-associated fibroblasts (cells within the tumor that encourage growth and metastasis) (CAFs) in oral cancer tissues. With this discovery, anti-PDGFRβ treatment could soon be combined with existing tumor treatments to provide a more effective cancer therapy.
› Verified 8 days ago
Nadia Ghallab, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Beach Conger, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4313 | |
Dr. Christopher Dwight Huston, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2264 | |
Beth Diane Kirkpatrick, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Burlington, VT 05401 Phone: 802-847-4594 | |
Dr. Richard Frank Branda, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 S. Prospect St, Burlington, VT 05401 Phone: 802-847-3827 Fax: 802-847-3510 | |
Lauren Suggs, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Magdalena Anna Zeglin, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |